| Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Note |
Title from PDF title page (viewed on Apr. 17, 2013). |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
ADVANCES IN MEDICINE AND BIOLOGY VOLUME 59 ; ADVANCES IN MEDICINE AND BIOLOGY VOLUME 59 ; Contents ; Preface ; Provision of Safe Blood Transfusion Services in a Low Income Setting in West Africa. Case Study of Nigeria ; Abstract ; Introduction ; History of Nigeria ; 1. Challenge of Transfusion-Transmissible Infections ; 1.1. Syphilis ; 1.2. Malaria ; 1.3. HCV ; 1.4. HIV ; 1.5. HBV ; 2. Absence of a Functional National Blood Transfusion Service ; 3. Challenges of Reliance on Commercial Remunerated and Family-Replacement Donors. |
|
4. Education, Cultural and Awareness -Related Challenges Associated with Blood Donors in Sub-Saharan Africa 5. Transfusion of Whole Blood Rather Than Component Therapy ; Whole Blood Transfusion ; 6. Lack of Effective Stewardship in the Management of Allogenic Blood by Stakeholders ; Avoidance of Wastage of Blood Components ; 7. Challenges Associated with the Absence of Red Cell Alloimmunization Testing Services ; 8. Challenges of SubOptimal Usage of Non- Pharmacologic and Pharmacologic Alternatives to Allogenic Blood ; Autologous Transfusion ; Normothermia ; Use of Erythropoietin. |
|
Use of Oral and Intravenous Iron Anti-fibrinolytics; Factor V11a ; Use of Restrictive Red Cell Transfusion Practices and Transfusion Triggers ; Use of Artificial Oxygen Carriers ; 9. Absence of Specially Selected Products to Meet the Special Transfusion Requirements of Certain Patients ; Irradiated Blood Component ; Indications for CMV Negative Blood Components ; Methelene Blue-Treated Plasma Products ; General Blood Product Requirements for Intrauterine/ Exchange Transfusion ; 10. Absence of Indication Coding Tool to Facilitate Effective Use of Blood Products. |
|
Indication Coding Tool for Red Cell Concentrates Indication Coding Tool for Fresh Frozen Plasma ; Information on the Use of FFP ; 11. Absence of Evidenced-Based Approach to the Management of Major Hemorrhages ; Evidence-Based Management Plan in Case of Massive Hemorrhage ; 12. Lack of Infrastructure (Absence of Uninterrupted Power Supply and Challenge of Cold Chain Management of Blood Product); 13. Absence of Stock of Emergency Group O Negative Blood for Emergency Use; Conclusion ; References ; Anticoagulant and Cytoprotective Protein C Pathways: Clinical Implications ; Abstract. |
|
1. Introduction 2. Anticoagulant Role of the PC Pathway ; 2.1. Lipids as Cofactors of the Anticoagulant APC ; 2.2. Clinical Implications of the PC Pathway in Thrombotic Pathologies; 3. Cytoprotective Role of the PC Pathway; 3.1. Clinical Implications of the PC Pathway in Inflammatory Pathologies ; Conclusion ; Acknowledgment ; References ; Bioanalytical Applications of Oligonucleotides; Electrochemical Biosensors, Based on Oligonucleotides Hybridization Detection, as Promising Bioanalytical Tools; Abstract ; Introduction. |
| Subject |
Clinical medicine.
|
|
Biology.
|
|
Clinical Medicine |
|
Biology |
|
Médecine clinique.
|
|
Biologie.
|
|
biology.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Biology
|
|
Clinical medicine
|
| Added Author |
Berhardt, Leon V.
|
| ISBN |
9781622578368 (electronic bk.) |
|
1622578368 (electronic bk.) |
| Standard No. |
DEBBG BV042794781 |
|
AU@ 000062325415 |
|
